Scientists seek samples to build better Cancer-Killing drugs
NCT ID NCT01087333
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 8 times
Summary
This study collects blood, urine, bone marrow, and tumor samples from people with hairy cell leukemia and other blood cancers, as well as from healthy volunteers. Researchers will use these samples to study the diseases and develop new treatments called immunotoxins, which use antibodies to deliver toxins directly to cancer cells. No treatment is given in this study. About 1,263 participants aged 18 and older will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT T CELL LYMPHOMA (ATL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Frailty check may steer safer cancer care for seniors
- Can 3D-Printed models unlock personalized blood cancer therapies?
- Could gratitude exercises aid blood cancer recovery?